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Running Title: The Procoagulant Nidus of the Ballooned Platelet 
 
Ballooned platelets are part of the haemostatic plug and thrombus architecture; however, it is 
unclear whether the procoagulant nidus of the ballooned platelet is the platelet body or balloon. 
Here we show that both the platelet body and balloon provide procoagulant surfaces but that 
these are temporally separated; procoagulant activity is primarily located on the platelet body at 
earlier stages of ballooning, whereas the ballooned membrane forms the predominant 
procoagulant surface at later time points. 
 
Advances in video microscopy have enabled the detailed elucidation of the structural changes 
human platelets undergo in the haemostatic process (1, 2). Recent studies are beginning to shed 
light on the physiological relevance of platelet membrane dynamics and its role in platelet-driven 
thrombosis (2-5). These studies show that platelets undergo a dramatic transformation to 
generate balloon-like structures with surface-exposed phosphatidylserine (PS), after collagen 
stimulation (2-5). However, the localisation of the procoagulant surface of the ballooned platelet, 
which amplifies coagulation, remains unclear. On the one hand, four-dimensional (4D) imaging 
showed that formation of membrane balloons (delineated by the yellow bracket in Fig. 1Ai) 
coincided with the formation of procoagulant microvesicles and the amplification of thrombin 
generation (2).  Other studies however infer that a part of the ballooned platelet termed the ‘cap’ 
(delineated by the cyan bracket in Fig. 1Ai), expresses a high density of surface PS and is more 
important for the acceleration of coagulation and thrombus formation (4, 5). In this letter, we 
provide evidence that unifies these observations.  
 
The procoagulant feature described as being the platelet cap (3-5) has recently been reported as 
the remnant platelet body in experiments observing membrane ballooning in real time (2). The 
platelet body (or cap) and the balloon are distinct parts of the activated platelet; strictly, the 
balloon is the inflated membrane of the platelet body (or cap) as shown in time lapse Images of 
Fig. 1Ai. We suggest that both the platelet body and the ballooned membrane are likely to provide 
important procoagulant surfaces, but are temporally separated so that the body is responsible for 
early PS exposure whereas the balloon, which has an extensive surface area, is responsible for a 
prolonged and substantial second wave of thrombin generation.  Differences in interpretation of 
the derivation of the platelet body (or cap) are due largely to whether the dynamics of ballooning 
were followed in real-time over a prolonged period or observed at single time points (2-6). 
Visualisation of platelet membrane ballooning in real-time by 4D imaging for 90 min reveals the 
time-dependent differential contribution of the remnant platelet body and the ballooned 
membrane to coagulation. We previously identified 3 distinct phases of platelet ballooning, which 
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are critical to the correct interpretation of the role of the ballooned membrane in the localisation 
and acceleration of coagulation at wound sites (2).  We had termed these phases Ph
1
, Ph
2
 and Ph
3
; 
where Phase 1 (Ph
1
) was associated with blebbing and bleb retraction, phase 2 corresponded to 
the rapid membrane expansion or ballooning phase and in phase 3 (Ph
3
), the expansion plateaued 
(2). 
 
Consistent with this, we show in Fig. 1A that annexin-V accumulates on the membrane of the 
platelet body alone from 0-7 min after adhesion to collagen, corresponding to phases Ph
1
 and Ph
2
 
of ballooning (Fig. 1Ai,ii), followed by binding subsequently to the ballooned membrane in early 
phase Ph
3
 (Fig. 1Ai,iii). The earlier time points correspond more closely to those used in other 
studies (4, 5) which had made similar observations of a higher density of annexin-V on the platelet 
body (or cap) compared to the ballooned membrane (2, 4, 5).  However, visualizing the formation 
of the balloon as well as the spatial distribution of annexin-V for over 45 min, revealed that the PS 
localisation switches from the remnant platelet body to the ballooned membrane in time (Fig. 1Ai-
iv), possibly mediated through a wave of Ca
2+
 along the membrane (2). Consistent with this, we 
show in Fig. 1Aiv, that at early phase 3 (10-50 min) and late phase 3 (≥ 90 min) adhesion to 
collagen, the ballooned membrane plays the predominant role in PS exposure. We also present 
data to indicate that the platelet body (or cap) is gradually lost, such that at later time points the 
only remaining structure is the platelet balloon. Fig. 1Av shows an example of this, where the 
platelet body (or cap) has completely disappeared. At present we do not know whether the 
platelet body is incorporated into the balloon, internalised or shed into the external environment. 
However, the presence of PS +ve microvesicles nearby (2) may suggest that it can potentially 
contribute to PS +ve membrane shedding into the external environment. Throughout their lifetime 
ballooned platelet membranes remain able to support not only annexin-V binding, but also active 
thrombin generation as demonstrated by use of the fluorogenic thrombin substrate peptide (Fig. 
1B; Movie S1). Likewise, consistent with annexin-V binding data (Fig. 1Aiv), thrombin generation 
was significantly higher at the platelet body when compared to the ballooned membrane at early 
time points (Phase 2, Fig. 1Bi, iii), but this reversed to higher thrombin generation on the 
ballooned membrane at later time points (early Phase 3, Fig. 1Bii, iii; Movie S1).   
 
Our 4D imaging data also clarify the nature of the platelet body (or cap) during ballooning (3-5, 7, 
8), clearly showing that what has previously been termed the platelet cap, is the remnant platelet 
body. Capping was originally described by Taylor et al., in lymphocytes (9) as a characteristic of 
certain motile cells, and is a readily reversible process induced by antibodies directed against 
lymphocyte surface immunoglobulins, causing them to cluster at one region of the cell surface (9). 
Data on platelet capping are limited but it is unlikely that human platelets actually undergo this 
process. The reported features of platelets described as capped (5) do not match the description 
by Taylor et al (9). For example, unlike classical capping, the process for capped platelet formation 
is irreversible and this phenotype shows striking similarities with previously characterised 
ballooned platelets (2, 10), the formation of which was driven by salt and water entry. Also, while 
cap formation in lymphocytes was attenuated by drugs inhibiting actin filaments network 
formation such as cytochalasin-B or D, these compounds promoted the formation of ballooned 
platelets after collagen stimulation (2). Capping in lymphocytes involves clustering of surface 
immunoglobulins at the cap region, resulting in distinct changes in surface morphology. To test 
whether the membrane characteristics of the platelet body differed from that of the ballooned 
membrane, we used high resolution scanning electron microscopy (SEM), simultaneously with 
imaging of platelets (of the same donor) fluorescently labelled with annexin-V after adhesion to 
collagen surface; we then identified the platelet phenotype by their morphology as previously 
described (2). While the results did not indicate that ballooned platelets are exclusively 
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procoagulant, it showed that procoagulant human platelet membrane surfaces displayed a 
‘cauliflower-like’ transformation, when compared to non-procoagulant platelets (compare Fig. 1C 
with 1D). Also, membrane undulations were similar at the region of the platelet body to that of 
the balloon (Fig. 1C) and we therefore failed to identify a distinct surface morphology of the 
platelet body that would suggest receptor clustering or ‘capping’ in this region.  
 
Although, the physiological significance of thrombin generation starting at the platelet body and 
then moving to the balloon is presently unknown, it may lie with the spatiotemporal importance 
of PS exposure in the developing thrombus. PS exposure on the platelet body begins almost 
immediately after platelet adhesion to collagen (2) and is likely to ensure rapid initiation of 
thrombin generation at wound sites. This may then become a seed procoagulant agonist, for the 
stimulation and recruitment of more platelets, as well as fibrin deposition at the wound site itself. 
The increased procoagulant surface provided by the balloon at later times will amplify thrombin 
generation, microvesiculation and hence coagulation. This differential contribution of the platelet 
body and balloon could be a way to propagate the thrombin gradient throughout a growing 
thrombus, and therefore temporally coordinate coagulation and microvesicle formation (11). From 
a physiological perspective we therefore suggest that the differential time lines of procoagulant 
activation enable platelets to generate thrombin on both a rapid timescale (from the cell body) 
and a more prolonged timescale (from the balloon). This may allow rapid development of platelet 
activation within the thrombus core whilst also allowing for more prolonged activation that will be 
required for consolidation and stabilisation of the thrombus at the site of injury. (12) 
 
In conclusion, the 4D imaging approach adopted here shows that what has been previously 
referred to as a cap is actually the remnant platelet body. We conclude that PS is predominantly 
expressed on the platelet body at earlier stages of ballooning, whereas the balloon surface itself 
forms the predominant procoagulant surface at later time points. The localisation and density of 
PS exposure at different time points may contribute to propagation of the thrombin gradient, and 
therefore coagulation, throughout a growing thrombus.  
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Figure Legend 
Figure 1: Spatio-temporal dynamics of the procoagulant response of human platelets in contact with 
collagen. Using spinning-disk confocal microscopy, washed platelets were monitored while adhering to 
collagen fibres. Fluorescence intensity against time was recorded in platelets pre-incubated with Alexa568-
Annexin-V. A: Chart and superimposed phase contrast and fluorescent annexin-V (red) images of the 
ballooning platelet captured the differential spatiotemporal accumulation of annexin-V on the platelet 
body (or cap) (indicated by cyan lines) and balloon (indicated by yellow lines). Sum intensity of annexin-V 
accumulated over time is plotted in A-ii & A-iii. The phases of membrane ballooning as previously described 
by Agbani et al., 2015 is annotated on A-iii and A-iv.  Number on images (A-i) corresponds to time points as 
indicated by the numbered arrows of chart (A-ii and A-iii). Sum annexin-V accumulated on the platelet 
body (or cap) and the balloon was evaluated for the various phases of membrane ballooning and plotted in 
A-iv. In A-v, Z-sections of a ballooned human platelet separated by 1µm is shown after 90 min. Platelet is 
loosely adherent to collagen matrix and stained with Alexa568-Annexin-V. B: By means of a fluorogenic 
thrombin substrate, Z-GGR-AMC, thrombin activity (magenta) was visualized in collagen adherent platelets 
of platelet rich plasma showing annexin-V rich balloons (orange). Related to Movie S1. B-i, B-ii show 3D 
images of these platelets at 5 and 15min, respectively. The body (or cap) and balloons of these conjoined 
platelets are delineated by cyan and yellow circles, respectively. The sum intensity of the thrombin 
substrate was evaluated and shown in B-iii, for both the platelet body (or cap) and the balloon.  C-D: show 
scanning electron microscopy (SEM) images of procoagulant (C) and non-procoagulant (D) phenotype of 
washed human platelets adherent to collagen. SEM images (C and D) and fluorescence live images (A-i) 
were derived from the same donor. Cyan and yellow brackets delineate the platelet body (or cap) and 
balloon, respectively in C. Data analysis was by Wilcoxon signed rank test, P<0.05 (*) was considered 
significant.  Scale bar represents 2 µm (A-i, A-v, & C) or 1 µm (B, D)’. Data are representative of platelets 
from 8 (A and B) and 4 (C and D) human donors. Details of the microscope and the software used for the 
image analysis are as previously reported by Agbani et al., 2015 (2). 
 
 
 

